The gradual resumption of research on campus entered phase two Thursday, allowing researchers to resume additional in-person work.
Buildings with experimental laboratory research will be prioritized when reopening and will resume activities at 20-25% occupancy, according to an email UC Berkeley Vice Chancellor for Research Randy Katz and Associate Vice Chancellor for Research Linda Rugg sent to campus researchers. They emphasized, however, that all meetings and work that can be done remotely should continue to be conducted remotely.
Building oversight committees will coordinate and oversee each building proposal, which will then be reviewed by department chairs and deans. Katz will give final approval to ensure compliance with campuswide guidelines on building density.
The first two buildings to reopen will be the Innovative Genomics Institute building, which houses campus’s COVID-19 testing facilities, and Stanley Hall. The next buildings include the College of Chemistry, Weill Hall and the Life Sciences Addition, which will be followed by other laboratory-intensive buildings.
A campus conversation livestream will be held June 23 to address questions about research on campus.
Check back for updates.